MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$61,458K
(-56.37%↓ Y/Y)
Unrealized gains (losses)
on...
$141K
(184.43%↑ Y/Y)
Net loss
-$61,599K
(-57.40%↓ Y/Y)
Product IBSRELA
$274,207K
Product XPHOZAH
$103,601K
Kyowa Kirin
Co.Ltd-License Agreement...
$15,625K
Knight Therapeutics
Inc-License Agreement...
$254K
License Agreement
Development...
$5,000K
Knight Therapeutics
Inc-License Agreement...
$88K
Loss before
provision for income taxes
-$60,630K
(-55.98%↓ Y/Y)
Provision for income taxes
$969K
(264.29%↑ Y/Y)
Other income, net
$8,745K
(-4.68%↓ Y/Y)
Product
$377,808K
Product Supply Revenue
$15,879K
Non Cash Royalty
Related To Sale Of Future...
$8,545K
License
$5,088K
Loss from operations
-$40,977K
(-46.61%↓ Y/Y)
Interest expense
$20,102K
(54.56%↑ Y/Y)
Total revenues
$407,320K
(22.09%↑ Y/Y)
Non-cash interest
expense related to the...
$8,296K
(17.04%↑ Y/Y)
Total costs and
operating expenses
$448,297K
(44.14%↑ Y/Y)
Selling, general and
administrative
$337,233K
(30.36%↑ Y/Y)
Research and development
$71,527K
(36.72%↑ Y/Y)
Cost of sales
$39,537K
(-21.80%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ARDELYX, INC. (ARDX)
ARDELYX, INC. (ARDX)